Also, COVID is waning/flattening in the Northern Hemisphere. I think countries in LA and Southern Hemusphere would be more likely to acccept a Mex approval. I think with the unblinded results they may approve for all stages. It’s important that Mex does this severe trial because we won’t be able to fill 390 patients. Let’s be realistic. GILD has that corner. However , as Remdesivir is not cheap, I don’t think other countries will want such an expensive/ ineffective drug. It was different with HCQ because it was so cheap.